🔴 MEDPAL AI is trading 5% down today with no clear company-specific explanation

MEDPAL AI is trading 5% down at £5.22, with no clear company-specific announcement explaining the decline.

• Price context is for September 4, 2026.
• The broader market backdrop is modestly positive, rather than sharply risk-off.
• The FDA’s August 28 approval expanding Mounjaro’s cardiovascular indication was highlighted by MedPal AI on September 1; it supports the business outlook but does not directly explain the September 4 decline.